Decision on additional contribution to the capital of Sopharma Rus OOO

Sofia, Bulgaria, December 20, 2024 – In accordance with the requirements of Art. 100t of the LPOS, Sopharma AD (SFA: Bulgarian Stock Exchange AD, SPH: Warsaw Stock Exchange) hereby informs that in order to ensure operational opportunities for growth and increase sales on the traditional markets where the Company operates, the Board of Directors has decided to make an additional contribution to its subsidiary “Sopharma Rus” OOO in the amount of EUR 12.3 million, not increasing the capital.